Agulo, Romelyn A.

HRN: 13-87-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2022
CEFUROXIME 1.5GM (VIAL)
11/25/2022
11/26/2022
IVT
1.5gms
Prior To OR
For EL USO Prophylaxis; Mature Cystic Ovarian Teratoma, Right
Waiting Final Action 
11/26/2022
CEFUROXIME 1.5GM (VIAL)
11/26/2022
11/27/2022
IVT
1.5g
Q8
Post Op Prophylaxis
Waiting Final Action 
11/27/2022
CEFUROXIME 500MG (TAB)
11/27/2022
12/04/2022
ORAL
500mg/tab
BID
S/P EL USO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: